(1888PressRelease)
March 06, 2009 - Gaithersburg, MD - Ocimum Biosolutions today unveiled its Biobanking Stimulus Package by offering its complete BiotrackerTM Biobanking Solution for $75,000 (applicable in US and Canada). A similar Stimulus Package is also available for European countries for €58,000. The Biobanking Stimulus Package includes Ocimum’s world-class BiotrackerTM for Biobanking software, Implementation, Training, and the First year of Support & Maintenance. The package is offered at a fixed price with guaranteed on-time delivery.
“In today’s challenging economic environment, research organizations are being called upon to improve their effectiveness and efficiency like never before. Ocimum feels that in order to meet this goal automation of critical research functions is the answer. At the same time, securing large capital budgets to enable automation is increasingly also a challenge. The result is that research organizations cannot afford not to automate their operations but often cannot afford the solutions that makes this feasible,” explained Anuradha Acharya, CEO of Ocimum Biosolutions. “At Ocimum Biosolutions, your needs have always driven our priorities and we feel that by offering our special Biobanking Stimulus Package, we will be able to significantly assist research organizations overcome these challenges and flourish.”
Biotracker’s™ Biobanking solution manages the collection, storage, processing and distribution of biological materials as well as the association of critical demographic data, clinical data, and biomarkers to these biospecimens. Biotracker™ for Biobanking maintains biospecimen genealogy with the ability to perform DNA/RNA extractions and also includes management of TMAs, CMA and LCM. BiotrackerTM is HIPAA, CLIA, HL7 and caBIG compliant.
The BiotrackerTM Biobanking solution also includes a web-based requester module and can support a “virtual” Biobanking network where there may be many sites or locations as well as collaborators. For organizations employing Biobanking in support of clinical trials and biomarker characterization, Biotracker has configurable Clinical Study Management attributes.
“At its simplest level software employed at Biobanks will show the location of biospecimens. Most organizations, however, want to go beyond this and be able to search within the Meta data, because it’s this annotated information that gives intrinsic value to the biospecimens. A lot of the information must be integrated in such a way as to remove any aspect of typographical errors”, said Dr. Howard Rosenberg, Executive Director – LIMS of Ocimum Biosolutions. “Biotracker supports Controlled Vocabulary (SNOMED, WHO, caBIG Thesaurus) so that queries for available biospecimens will return all of the collection by diagnosis, disease type, etc. This as well as many other unique capabilities makes the Biotracker Biobanking solution the most complete on the market today.”
More information about the Biotracker Biobanking solution and the Biobanking Stimulus package is available at http://www.ocimumbio.com/75k.
###
